SeaStar Medical Holding(ICU)
$0.78-0.07 (-8.44%)
ICU
SeaStar Medical Holding financials statements
$0.78
At close:-0.07 (-8.44%)
Want to see ICU full AI Analyst Report?
SeaStar Medical Holding (ICU) Ratios
536 Followers
SeaStar Medical Holding Ratios
ICU's free cash flow for Q3 2026 was $-3.37M. For the 2026 fiscal year, ICU's free cash flow was increased by $0.00 and operating cash flow was $-3.37M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.63 | 0.55 | 0.18 | 0.09 | 0.19 |
| Quick Ratio | 3.61 | 0.55 | 0.18 | 0.09 | 0.19 |
| Cash Ratio | 3.20 | 0.27 | 0.01 | 0.00 | 0.16 |
| Solvency Ratio | -3.25 | -3.63 | -0.70 | -0.51 | -1.34 |
| Operating Cash Flow Ratio | -3.63 | -2.34 | -0.79 | -0.48 | -1.64 |
| Short-Term Operating Cash Flow Coverage | -25.90 | -27.89 | -2.17 | -6.62 | -2.15 |
| Net Current Asset Value | $ 9.84M | $ -3.08M | $ -15.07M | $ -22.28M | $ -2.82M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.12 | 2.58 | 2.91 | 4.35 |
| Debt-to-Equity Ratio | 0.05 | -0.26 | -0.65 | -0.43 | -0.93 |
| Debt-to-Capital Ratio | 0.05 | -0.36 | -1.90 | -0.74 | -13.52 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.45 | -0.58 | -0.09 |
| Financial Leverage Ratio | 1.36 | -2.13 | -0.25 | -0.15 | -0.21 |
| Debt Service Coverage Ratio | -14.19 | -30.06 | -1.91 | -6.39 | -1.69 |
| Interest Coverage Ratio | -37.01 | -73.12 | -13.15 | -18.43 | -20.99 |
| Debt to Market Cap | 0.01 | 0.08 | 0.95 | 0.17 | 0.02 |
| Interest Debt Per Share | 0.04 | 2.18 | 117.23 | 181.46 | 54.33 |
| Net Debt to EBITDA | 0.95 | 0.05 | -0.80 | -0.76 | -0.48 |
| Profitability Margins | |||||
| Gross Profit Margin | 95.71% | 100.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -981.85% | -18209.63% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -981.85% | -18209.63% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -986.63% | -13216.30% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -984.36% | -18390.37% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -984.60% | -18392.59% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -984.60% | -18392.59% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.02% | 100.01% | 100.00% | 100.01% | 99.98% |
| EBT Per EBIT | 99.77% | 139.15% | 184.60% | 105.00% | 103.33% |
| Return on Assets (ROA) | -85.82% | -533.06% | -746.71% | -401.25% | -762.19% |
| Return on Equity (ROE) | -116.65% | 1137.43% | 189.13% | 58.71% | 163.21% |
| Return on Capital Employed (ROCE) | -116.89% | 817.32% | 149.06% | 88.55% | 176.76% |
| Return on Invested Capital (ROIC) | -111.28% | 1108.89% | 296.72% | 97.29% | 3200.02% |
| Return on Tangible Assets | -85.82% | -533.06% | -746.71% | -401.25% | -762.19% |
| Earnings Yield | -24.42% | -341.85% | -273.38% | -22.81% | -3.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.21 | 1.21 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.09 | 0.03 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.36 | -0.02 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -6004.05 | 302.81 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 70.10 | 302.81 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 454.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 6528.68 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 524.63 | 302.81 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.66 | -42.75 | -118.65 | -149.51 | -98.04 |
| Free Cash Flow Per Share | -0.66 | -42.75 | -118.65 | -149.51 | -98.04 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -25.90 | -27.89 | -1.13 | -0.88 | -1.95 |
| Operating Cash Flow to Sales Ratio | -11.02 | -118.57 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -27.33% | -220.38% | -107.18% | -14.59% | -3.82% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.41 | -0.29 | -0.37 | -4.38 | -29.14 |
| Price-to-Sales (P/S) Ratio | 40.32 | 53.80 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 4.78 | -3.33 | -0.69 | -2.57 | -47.56 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.66 | -0.45 | -0.93 | -6.86 | -26.19 |
| Price-to-Operating Cash Flow Ratio | -3.66 | -0.45 | -0.93 | -6.86 | -26.19 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | -0.01 | -0.03 | -0.00 |
| Enterprise Value Multiple | -3.16 | -0.24 | -1.66 | -5.38 | -31.02 |
| Enterprise Value | 38.30M | 6.02M | 18.50M | 62.22M | 136.04M |
| EV to EBITDA | -3.16 | -0.24 | -1.66 | -5.38 | -31.02 |
| EV to Sales | 31.04 | 44.58 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.82 | -0.38 | -1.80 | -7.98 | -26.60 |
| EV to Operating Cash Flow | -2.82 | -0.38 | -1.80 | -7.98 | -26.60 |
| Tangible Book Value Per Share | 0.50 | -5.83 | -160.01 | -398.26 | -53.98 |
| Shareholders’ Equity Per Share | 0.50 | -5.83 | -160.01 | -398.26 | -53.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | 0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.06 | 0.36 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.59 | -66.32 | -302.63 | -233.83 | -88.11 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.01 | 1.04 | 1.05 | 1.05 |
| Research & Development to Revenue | 6.09 | 67.44 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 4.73 | 65.72 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.51 | 6.57 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.12 | 0.64 | 0.39 | 0.64 | 1.11 |
Currency in USD

